Notably, the spread of CD326+ cancer cells into the blood circulation is a common event and 77.5% of all analyzed patients exhibited these cells in their peripheral blood pre-operatively, while 45.0% exhibited CD26+/CD326− cells. Here, EPCAM is linked to cancer.